Christian Auclair

USPTO Granted Patents = 10 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 21)

Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 26(Granted Patents)

Location History:

Paris, FR (2003 - 2019)
Saint Arnoult en Yvelines, FR (2022)
Saint-Arnoult-en-Yvelines, FR (2018 - 2023)

Company Filing History:

5 out of 5,072

Centre National De La Recherche Scientifique

Ecole Normale Superieure De Cachan

patents

4. 1 out of 1

Paris-sud, Universite

Medizinische Universitat Wien

9. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11850234 - Enhancement of cancer treatment efficiency via the sphingosine-1-phosphate pathway (2023-12-26),

2. 11351146 - Topical compositions for the treatment of cutaneous leishmaniasis (2022-06-07),

3. 11077087 - Compositions comprising dihydroquercetin for use in methods for treating herpes (2021-08-03),

4. 10383955 - Human mast cell lines, preparation and uses (2019-08-20),

5. 9956200 - Compositions comprising dihydroquercetin for use in methods for treating the effects associated with skin inflammatory disorders (2018-05-01),

6. 9271956 - Companion cosmetic compositions (2016-03-01),

7. 8828718 - Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements (2014-09-09),

8. 8227433 - Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis (2012-07-24),

9. 7491505 - Method for analyzing tumor aggressivity comprising measurement of polymerized actin (2009-02-17),

10. 6670377 - Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof (2003-12-30),

Title: The Innovative Contributions of Christian Auclair

Introduction

Christian Auclair is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in cancer treatment and infectious diseases. With a total of 10 patents to his name, Auclair's work has the potential to impact the lives of many patients.

Latest Patents

Among his latest patents, Auclair has developed methods to enhance cancer treatment efficiency via the sphingosine-1-phosphate pathway. This invention focuses on using a neoadjuvant prior to chemotherapy, specifically a sphingosine-1-phosphate pathway activator. This activator enhances chemotherapy efficiency by normalizing the intratumoral vascular network, thereby promoting the effects of sequential administration of anticancer agents or radiotherapy. Additionally, he has created topical compositions for the treatment of cutaneous leishmaniasis. This composition includes a combination of a (halogenoacetamido)benzoate, a flavonol, and a terpene, aimed at treating both the parasitic infection and the skin inflammation caused by leishmaniasis.

Career Highlights

Christian Auclair has worked with notable organizations such as the Centre National de la Recherche Scientifique and Bionoox Suisse SA. His experience in these institutions has allowed him to develop innovative solutions to complex medical challenges.

Collaborations

Some of his notable coworkers include Frédéric Subra and Khalid Mekouar. Their collaborative efforts have contributed to the advancement of Auclair's research and inventions.

Conclusion

Christian Auclair's innovative work in the medical field showcases his dedication to improving treatment options for cancer and infectious diseases. His patents reflect a commitment to advancing healthcare through scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.